Cargando…
Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum
Coronavirus disease 2019 (COVID-19) is a viral infection that can, in severe cases, result in cytokine storm, systemic inflammatory response and coagulopathy that is prognostic of poor outcomes. While some, but not all, laboratory findings appear similar to sepsis-associated disseminated intravascul...
Autores principales: | Barnes, Geoffrey D., Burnett, Allison, Allen, Arthur, Blumenstein, Marilyn, Clark, Nathan P., Cuker, Adam, Dager, William E., Deitelzweig, Steven B., Ellsworth, Stacy, Garcia, David, Kaatz, Scott, Minichiello, Tracy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7241581/ https://www.ncbi.nlm.nih.gov/pubmed/32440883 http://dx.doi.org/10.1007/s11239-020-02138-z |
Ejemplares similares
-
Thromboembolic prevention and anticoagulant therapy during the COVID-19 pandemic: updated clinical guidance from the anticoagulation forum
por: Barnes, Geoffrey D, et al.
Publicado: (2022) -
Management of venous thromboembolism: clinical guidance from the Anticoagulation Forum
por: Ansell, Jack E.
Publicado: (2016) -
Guidance for the practical management of the heparin anticoagulants in the treatment of venous thromboembolism
por: Smythe, Maureen A., et al.
Publicado: (2016) -
Trends in Venous Thromboembolism Anticoagulation in Patients Hospitalized With COVID-19
por: Vaughn, Valerie M., et al.
Publicado: (2021) -
A call to action for anticoagulation stewardship
por: Burnett, Allison E., et al.
Publicado: (2022)